Obliterative (constrictive) bronchiolitis

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 5, 2012, Pages 509-532

  Lynch, Josephp ^a   Weigt, S Samuel ^a   Derhovanessian, Ariss ^a   Fishbein, Michaelc ^a   Gutierrez, Antonio ^a   Belperio, Johna ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bronchiolitis obliterans; bronchiolitis obliterans syndrome; chronic lung allograft rejection; constrictive bronchiolitis; hematopoietic stem cell transplant; obliterative bronchiolitis

Indexed keywords

ALEMTUZUMAB; ALKYLATING AGENT; AZATHIOPRINE; AZITHROMYCIN; BASILIXIMAB; BLEOMYCIN; BUSULFAN; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; ETANERCEPT; FLUTICASONE; HLA B40 ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MACROLIDE; METHOTREXATE; METHOXSALEN; METHYLPREDNISOLONE; MONTELUKAST; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLAMINE; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; UNINDEXED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; AUTOIMMUNE DISEASE; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DUST EXPOSURE; ENTERITIS; EPIDEMIOLOGY; FORCED VITAL CAPACITY; GASTROESOPHAGEAL REFLUX; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN A NEPHROPATHY; INFECTION; INFLUENZA; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; LYMPHOCYTOSIS; LYSINURIC PROTEIN INTOLERANCE; MIXED CONNECTIVE TISSUE DISEASE; MORBIDITY; MYCOPLASMA PNEUMONIAE; PARAINFLUENZA VIRUS INFECTION; PARANEOPLASTIC PEMPHIGUS; PARTICULATE MATTER; PATHOGENESIS; PNEUMONIA; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PUVA; RADIOGRAPHY; RESPIRATORY DISTRESS SYNDROME; RETRANSPLANTATION; RHEUMATOID ARTHRITIS; RISK FACTOR; SCLERODERMA; SJOEGREN SYNDROME; STAPHYLOCOCCUS AUREUS; STOMACH FUNDOPLICATION; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T CELL LYMPHOMA; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; UNSPECIFIED SIDE EFFECT;

AIRWAY OBSTRUCTION; ANIMALS; BRONCHIOLES; BRONCHIOLITIS OBLITERANS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866492158     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1325161     Document Type: Article

References (424)

1. Ryu J. H. Classification and approach to bronchiolar diseases. Curr Opin Pulm Med: 2006; 12 2 145 151 (Pubitemid 44384790)
2. Ryu J. H., Myers J. L., Swensen S. J. Bronchiolar disorders. Am J Respir Crit Care Med: 2003; 168 11 1277 1292 (Pubitemid 37487320)
3. Wright J. L., Cagle P., Churg A., Colby T. V., Myers J. Diseases of the small airways. Am Rev Respir Dis: 1992; 146 1 240 262
4. Poletti V., Costabel U. Bronchiolar disorders: classification and diagnostic approach. Semin Respir Crit Care Med: 2003; 24 5 457 464
5. Poletti V., Casoni G., Zompatori M., Carolini A., Chilosi M. Obliterative bronchiolitis: classification, causes, and overview. In: Lynch J. P. III., ed. Interstitial Pulmonary and Bronchiolar Disorders. New York, NY Informa Healthcare USA: 2008; 227 525 542
6. Poletti V., Casoni G., Zompatori M., Chilosi M. Bronchiolitis. In: Costabel U., du Bois R. M., Egan J. J., eds. Diffuse Parenchymal Lung Disease. Prog Respir Res. Basel, Switzerland Karger: 2007; 36 292 306
7. Garg K., Lynch D. A., Newell J. D., King T. E. Jr. Proliferative and constrictive bronchiolitis: classification and radiologic features. AJR Am J Roentgenol: 1994; 162 4 803 808 (Pubitemid 24115859)
8. Ezri T., Kunichezky S., Eliraz A., Soroker D., Halperin D., Schattner A. Bronchiolitis obliteranscurrent concepts. Q J Med: 1994; 87 1 1 10
9. Belperio J. A., Lake K., Tazelaar H., Keane M. P., Strieter R. M., Lynch J. P. III. Bronchiolitis obliterans syndrome complicating lung or heart-lung transplantation. Semin Respir Crit Care Med: 2003; 24 5 499 530 (Pubitemid 37542846)
10. Lynch J. P. III, Saggar R., Suh R. D., Fishbein M. C. Bronchiolar disorders. In: Baughman R. P., Carbone R. G., Bottino G., eds. Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide. New York, NY Humana Press: 2009; 111 138
11. Alasaly K., Muller N., Ostrow D. N., Champion P., FitzGerald J. M. Cryptogenic organizing pneumonia: a report of 25 cases and a review of the literature. Medicine (Baltimore): 1995; 74 4 201 211
12. Cordier J. F. Organising pneumonia. Thorax: 2000; 55 4 318 328
13. Schlesinger C., Koss M. N. The organizing pneumonias: an update and review. Curr Opin Pulm Med: 2005; 11 5 422 430 (Pubitemid 41291087)
14. Belperio J. A., Weigt S. S., Fishbein M. C., Lynch J. P. III. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc: 2009; 6 1 108 121
15. Weigt S. S., Wallace W. D., Derhovanessian A., et al. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med: 2010; 31 2 189 207
16. Scott A. I., Sharples L. D., Stewart S. Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies. Drugs: 2005; 65 6 761 771 (Pubitemid 40593625)
17. Knoop C., Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med: 2006; 27 5 521 533 (Pubitemid 44672555)
18. Chien J. W., Martin P. J., Gooley T. A., et al. Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation. Am J Respir Crit Care Med: 2003; 168 2 208 214 (Pubitemid 36920975)
19. Kotloff R. M., Ahya V. N., Crawford S. W. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med: 2004; 170 1 22 48 (Pubitemid 38997749)
20. Khalid M., Al Saghir A., Saleemi S., et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J: 2005; 25 3 490 493 (Pubitemid 40340107)
21. Gunn M. L., Godwin J. D., Kanne J. P., Flowers M. E., Chien J. W. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging: 2008; 23 4 244 250
22. Filipovich A. H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant: 2005; 11 12 945 956 (Pubitemid 41754712)
23. Afessa B., Litzow M. R., Tefferi A. Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant: 2001; 28 5 425 434 (Pubitemid 33069620)
24. Afessa B., Peters S. G. Major complications following hematopoietic stem cell transplantation. Semin Respir Crit Care Med: 2006; 27 3 297 309 (Pubitemid 44061631)
25. White E. S., Tazelaar H. D., Lynch J. P. III. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med: 2003; 24 5 543 566
26. Schwarz M. I., Lynch D. A., Tuder R. Bronchiolitis obliterans: the lone manifestation of rheumatoid arthritis? Eur Respir J: 1994; 7 4 817 820 (Pubitemid 24122981)
27. King T. E. Jr. Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic. Semin Respir Crit Care Med: 2003; 24 5 567 576 (Pubitemid 37542849)
28. Fischer G. B., Sarria E. E., Mattiello R., Mocelin H. T., Castro-Rodriguez J. A. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev: 2010; 11 4 233 239
29. Boswell R. T., McCunney R. J. Bronchiolitis obliterans from exposure to incinerator fly ash. J Occup Environ Med: 1995; 37 7 850 855
30. Mann J. M., Sha K. K., Kline G., Breuer F. U., Miller A. World Trade Center dyspnea: bronchiolitis obliterans with functional improvement: a case report. Am J Ind Med: 2005; 48 3 225 229 (Pubitemid 41306592)
31. Churg A., Wright J. L. Bronchiolitis caused by occupational and ambient atmospheric particles. Semin Respir Crit Care Med: 2003; 24 5 577 584
32. Couture C., Colby T. V. Histopathology of bronchiolar disorders. Semin Respir Crit Care Med: 2003; 24 5 489 498 (Pubitemid 37542845)
33. Kanwal R. Bronchiolitis obliterans in workers exposed to flavoring chemicals. Curr Opin Pulm Med: 2008; 14 2 141 146 (Pubitemid 351324803)
34. van Rooy F. G., Rooyackers J. M., Prokop M., Houba R., Smit L. A., Heederik D. J. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med: 2007; 176 5 498 504 (Pubitemid 47358104)
35. Kreiss K., Gomaa A., Kullman G., Fedan K., Simoes E. J., Enright P. L. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med: 2002; 347 5 330 338 (Pubitemid 34815355)
36. Akpinar-Elci M., Travis W. D., Lynch D. A., Kreiss K. Bronchiolitis obliterans syndrome in popcorn production plant workers. Eur Respir J: 2004; 24 2 298 302 (Pubitemid 39139800)
37. Adler B. D., Padley S. P., Müller N. L., Remy-Jardin M., Remy J. Chronic hypersensitivity pneumonitis: high-resolution CT and radiographic features in 16 patients. Radiology: 1992; 185 1 91 95
38. Hernández J. I., Gómez-Román J., Rodrigo E., et al. Bronchiolitis obliterans and IgA nephropathy: a new cause of pulmonary-renal syndrome. Am J Respir Crit Care Med: 1997; 156 2 Pt 1 665 668
39. Ito M., Nakagawa A., Hirabayashi N., Asai J. Bronchiolitis obliterans in ataxia-telangiectasia. Virchows Arch: 1997; 430 2 131 137 (Pubitemid 27121112)
40. Parto K., Svedström E., Majurin M. L., Härkönen R., Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest: 1993; 104 4 1176 1182 (Pubitemid 23306073)
41. Chang H., Wang J. S., Tseng H. H., Lai R. S., Su J. M. Histopathological study of Sauropus androgynus-associated constrictive bronchiolitis obliterans: a new cause of constrictive bronchiolitis obliterans. Am J Surg Pathol: 1997; 21 1 35 42
42. Mahajan L., Kay M., Wyllie R., Steffen R., Goldfarb J. Ulcerative colitis presenting with bronchiolitis obliterans organizing pneumonia in a pediatric patient. Am J Gastroenterol: 1997; 92 11 2123 2124 (Pubitemid 27476270)
43. Mahadeva R., Walsh G., Flower C. D., Shneerson J. M. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J: 2000; 15 1 41 48 (Pubitemid 30068934)
44. Schlesinger C., Meyer C. A., Veeraraghavan S., Koss M. N. Constrictive (obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature. Ann Diagn Pathol: 1998; 2 5 321 334 (Pubitemid 128646573)
45. D'Ovidio F., Mura M., Tsang M., et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg: 2005; 129 5 1144 1152 (Pubitemid 40631438)
46. Lee J. S., Brown K. K., Cool C., Lynch D. A. Diffuse pulmonary neuroendocrine cell hyperplasia: radiologic and clinical features. J Comput Assist Tomogr: 2002; 26 2 180 184 (Pubitemid 34233361)
47. Aguayo S. M., Miller Y. E., Waldron J. A. Jr., et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med: 1992; 327 18 1285 1288
48. Kraft M., Mortenson R. L., Colby T. V., Newman L., Waldron J. A. Jr, King T. E. Jr. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis: 1993; 148 4 Pt 1 1093 1101 (Pubitemid 23301237)
49. Turton C. W., Williams G., Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax: 1981; 36 11 805 810 (Pubitemid 12198226)
50. Epler G. R., Colby T. V., McLoud T. C., Carrington C. B., Gaensler E. A. Bronchiolitis obliterans organizing pneumonia. N Engl J Med: 1985; 312 3 152 158 (Pubitemid 15192862)
51. Kelly K., Hertz M. I. Obliterative bronchiolitis. Clin Chest Med: 1997; 18 2 319 338 (Pubitemid 27247140)
52. Katzenstein A. L., Myers J. L., Prophet W. D., Corley L. S. III, Shin M. S. Bronchiolitis obliterans and usual interstitial pneumonia: a comparative clinicopathologic study. Am J Surg Pathol: 1986; 10 6 373 381 (Pubitemid 16066439)
53. Geddes D. M., Corrin B., Brewerton D. A., Davies R. J., Turner-Warwick M. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med: 1977; 46 184 427 444 (Pubitemid 8241107)
54. Epler G. R. Bronchiolar disorders with airflow obstruction. Curr Opin Pulm Med: 1996; 2 2 134 140 (Pubitemid 126440689)
55. Butland R. J., Cole P., Citron K. M., Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med: 1981; 50 197 63 75 (Pubitemid 11099596)
56. Shadick N. A., Fanta C. H., Weinblatt M. E., O'Donnell W., Coblyn J. S. Bronchiectasis: a late feature of severe rheumatoid arthritis. Medicine (Baltimore): 1994; 73 3 161 170
57. Costabel U. BAL characteristics of the bronchiolar diseases. In: Epler G. R., ed. Diseases of the Bronchioles. New York Raven Press: 1994; 59 76
58. Kindt G. C., Weiland J. E., Davis W. B., Gadek J. E., Dorinsky P. M. Bronchiolitis in adults: a reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis: 1989; 140 2 483 492
59. DiGiovine B., Lynch J. P. III, Martinez F. J., et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol: 1996; 157 9 4194 4202
60. Hansell D. M., Rubens M. B., Padley S. P., Wells A. U. Obliterative bronchiolitis: individual CT signs of small airways disease and functional correlation. Radiology: 1997; 203 3 721 726 (Pubitemid 27227420)
61. King T. E. Jr. Bronchiolitis. In: Fishman, ed. Fishman's Pulmonary Diseases and Disorders. 3rd ed. New York, NY McGraw Hill: 1997; 825 847
62. Padley S. P., Adler B. D., Hansell D. M., Müller N. L. Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests. Clin Radiol: 1993; 47 4 236 240 (Pubitemid 23107895)
63. Perez T., Remy-Jardin M., Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med: 1998; 157 5 Pt 1 1658 1665
64. Aquino S. L., Webb W. R., Golden J. Bronchiolitis obliterans associated with rheumatoid arthritis: findings on HRCT and dynamic expiratory CT. J Comput Assist Tomogr: 1994; 18 4 555 558 (Pubitemid 24222202)
65. Verschakelen J. A. Imaging of the small airways. Semin Respir Crit Care Med: 2003; 24 5 473 488
66. Pipavath S. J., Lynch D. A., Cool C., Brown K. K., Newell J. D. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol: 2005; 185 2 354 363
67. Müller N. L., Miller R. R. Diseases of the bronchioles: CT and histopathologic findings. Radiology: 1995; 196 1 3 12
68. Hansell D. M. HRCT of obliterative bronchiolitis and other small airways diseases. Semin Roentgenol: 2001; 36 1 51 65 (Pubitemid 32147354)
69. Lee E. S., Gotway M. B., Reddy G. P., Golden J. A., Keith F. M., Webb W. R. Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis. Radiology: 2000; 216 2 472 477 (Pubitemid 30599868)
70. Lynch J. P. III, Belperio J. A., Flint A., Martinez F. J. Bronchiolar complications of connective tissue disorders. Semin Respir Crit Care Med: 1999; 20 149 168 (Pubitemid 29189736)
71. Epler G. R., Colby T. V. The spectrum of bronchiolitis obliterans. Chest: 1983; 83 2 161 162 (Pubitemid 13185676)
72. Halpin D. MG, Geddes D. M. Rheumatoid arthritis and connective-tissue disease related bronchiolitis obliterans. In: Epler G. R., ed. Diseases of the Bronchioles. New York, NY Raven Press: 1994; 231 240
73. Lynch J. P. III, McCune W. J. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am J Respir Crit Care Med: 1997; 155 2 395 420 (Pubitemid 27085778)
74. Gerhardt S. G., McDyer J. F., Girgis R. E., Conte J. V., Yang S. C., Orens J. B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med: 2003; 168 1 121 125 (Pubitemid 37046642)
75. Yates B., Murphy D. M., Forrest I. A., et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med: 2005; 172 6 772 775 (Pubitemid 41324235)
76. Verleden G. M., Dupont L. J. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation: 2004; 77 9 1465 1467 (Pubitemid 38668447)
77. Shitrit D., Bendayan D., Gidon S., Saute M., Bakal I., Kramer M. R. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant: 2005; 24 9 1440 1443 (Pubitemid 41247833)
78. Vos R., Vanaudenaerde B. M., Ottevaere A., et al. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? J Heart Lung Transplant: 2010; 29 12 1358 1368
79. Friedlander A. L., Albert R. K. Chronic macrolide therapy in inflammatory airways diseases. Chest: 2010; 138 5 1202 1212
80. Pigula F. A., Griffith B. P., Zenati M. A., Dauber J. H., Yousem S. A., Keenan R. J. Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg: 1997; 64 6 1630 1634 (Pubitemid 28066530)
81. Redel-Montero J., Bujalance-Cabrera C., Vaquero-Barrios J. M., et al. Lung transplantation for bronchiolitis obliterans after allogenic bone marrow transplantation. Transplant Proc: 2010; 42 8 3023 3025
82. Novick R. J., Stitt L. W., Al-Kattan K., et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg: 1998; 65 1 227 234 (Pubitemid 28105898)
83. Lai R. S., Wang J. S., Wu M. T., Hsu H. K. Lung transplantation in bronchiolitis obliterans associated with vegetable consumption. Lancet: 1998; 352 9122 117 118
84. Oonakahara K., Matsuyama W., Higashimoto I., et al. Outbreak of Bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japanalert of food-associated pulmonary disorders from Japan. Respiration: 2005; 72 2 221 (Pubitemid 40591540)
85. Hertz M. I., Aurora P., Christie J. D., et al. Scientific Registry of the International Society for Heart and Lung Transplantation: introduction to the 2009 Annual Reports. J Heart Lung Transplant: 2009; 28 10 989 992
86. Christie J. D., Edwards L. B., Kucheryavaya A. Y., et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report2011. J Heart Lung Transplant: 2011; 30 10 1104 1122
87. Verleden G. M., Dupont L. J., Van Raemdonck D. E. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J: 2005; 25 2 221 224 (Pubitemid 40246520)
88. Saggar R., Ross D. J., Saggar R., et al. Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft. Am J Transplant: 2008; 8 9 1921 1930
89. Sharples L. D., McNeil K., Stewart S., Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant: 2002; 21 2 271 281 (Pubitemid 34130545)
90. Girgis R. E., Tu I., Berry G. J., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant: 1996; 15 12 1200 1208 (Pubitemid 26428395)
91. Heng D., Sharples L. D., McNeil K., Stewart S., Wreghitt T., Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant: 1998; 17 12 1255 1263 (Pubitemid 29013408)
92. Husain A. N., Siddiqui M. T., Holmes E. W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med: 1999; 159 3 829 833 (Pubitemid 29137781)
93. Glanville A. R. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med: 2006; 27 5 480 491 (Pubitemid 44672551)
94. Khalifah A. P., Hachem R. R., Chakinala M. M., et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant: 2005; 5 8 2022 2030 (Pubitemid 41039881)
95. Hachem R. R., Khalifah A. P., Chakinala M. M., et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation: 2005; 80 10 1406 1413 (Pubitemid 41803621)
96. Hopkins P. M., Aboyoun C. L., Chhajed P. N., et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med: 2004; 170 9 1022 1026 (Pubitemid 39425700)
97. Stewart S., Fishbein M. C., Snell G. I., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant: 2007; 26 12 1229 1242 (Pubitemid 350256994)
98. Yousem S. A., Berry G. J., Cagle P. T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant: 1996; 15 1 Pt 1 1 15 (Pubitemid 26056119)
99. Tazelaar H. D., Prop J., Nieuwenhuis P., Billingham M. E., Wildevuur C. R. Airway pathology in the transplanted rat lung. Transplantation: 1988; 45 5 864 869
100. Estenne M., Hertz M. I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med: 2002; 166 4 440 444
101. Glanville A. R., Aboyoun C. L., Havryk A., Plit M., Rainer S., Malouf M. A. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med: 2008; 177 9 1033 1040 (Pubitemid 351717599)
102. Burton C. M., Iversen M., Scheike T., Carlsen J., Andersen C. B. Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation. J Heart Lung Transplant: 2008; 27 10 1128 1134
103. Sundaresan S., Mohanakumar T., Smith M. A., et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation: 1998; 65 5 648 653 (Pubitemid 28128933)
104. Chalermskulrat W., Neuringer I. P., Schmitz J. L., et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest: 2003; 123 6 1825 1831 (Pubitemid 36706700)
105. Keogh A., Kaan A., Doran T., Macdonald P., Bryant D., Spratt P. HLA mismatching and outcome in heart, heart-lung, and single lung transplantation. J Heart Lung Transplant: 1995; 14 3 444 451
106. Wisser W., Wekerle T., Zlabinger G., et al. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation. J Heart Lung Transplant: 1996; 15 12 1209 1216 (Pubitemid 26428396)
107. Kroshus T. J., Kshettry V. R., Savik K., John R., Hertz M. I., Bolman R. M. III. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg: 1997; 114 2 195 202 (Pubitemid 27364208)
108. Quantz M. A., Bennett L. E., Meyer D. M., Novick R. J. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant: 2000; 19 5 473 479 (Pubitemid 30249086)
109. Stanford R. E., Ahmed S., Hodson M., Banner N. R., Rose M. L. A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis. Am J Transplant: 2003; 3 6 736 742 (Pubitemid 36745247)
110. Duncan S. R., Leonard C., Theodore J., et al. Oligoclonal CD4(+) T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med: 2002; 165 10 1439 1444 (Pubitemid 34522950)
111. Palmer S. M., Davis R. D., Hadjiliadis D., et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation: 2002; 74 6 799 804
112. Jaramillo A., Smith C. R., Maruyama T., Zhang L., Patterson G. A., Mohanakumar T. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol: 2003; 64 5 521 529 (Pubitemid 36504691)
113. Maruyama T., Jaramillo A., Narayanan K., Higuchi T., Mohanakumar T. Induction of obliterative airway disease by anti-HLA class I antibodies. Am J Transplant: 2005; 5 9 2126 2134 (Pubitemid 41648459)
114. Hachem R. R., Yusen R. D., Meyers B. F., et al. Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant: 2010; 29 9 973 980
115. Daud S. A., Yusen R. D., Meyers B. F., et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med: 2007; 175 5 507 513 (Pubitemid 46354255)
116. Christie J. D., Kotloff R. M., Ahya V. N., et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med: 2005; 171 11 1312 1316 (Pubitemid 40740741)
117. Ruttmann E., Geltner C., Bucher B., et al. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation. Transplantation: 2006; 81 10 1415 1420 (Pubitemid 43847152)
118. Chmiel C., Speich R., Hofer M., et al. Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis: 2008; 46 6 831 839 (Pubitemid 351417183)
119. Paraskeva M., Bailey M., Levvey B. J., et al. Cytomegalovirus replication within the lung allograft is associated with bronchiolitis obliterans syndrome. Am J Transplant: 2011; 11 10 2190 2196
120. Snyder L. D., Finlen-Copeland C. A., Turbyfill W. J., Howell D., Willner D. A., Palmer S. M. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med: 2010; 181 12 1391 1396
121. Weigt S. S., Elashoff R. M., Keane M. P., et al. Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation. Am J Transplant: 2008; 8 7 1512 1522 (Pubitemid 351989504)
122. Khalifah A. P., Hachem R. R., Chakinala M. M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med: 2004; 170 2 181 187 (Pubitemid 38925165)
123. Kumar D., Erdman D., Keshavjee S., et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant: 2005; 5 8 2031 2036 (Pubitemid 41039882)
124. Vilchez R. A., Dauber J., McCurry K., Iacono A., Kusne S. Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function. Am J Transplant: 2003; 3 2 116 120 (Pubitemid 36323108)
125. Gerna G., Vitulo P., Rovida F., et al. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients. J Med Virol: 2006; 78 3 408 416 (Pubitemid 43327842)
126. Botha P., Archer L., Anderson R. L., et al. Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation: 2008; 85 5 771 774 (Pubitemid 351398256)
127. Vos R., Vanaudenaerde B. M., Geudens N., Dupont L. J., Van Raemdonck D. E., Verleden G. M. Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? Eur Respir J: 2008; 31 5 1037 1045
128. Weigt S. S., Elashoff R. M., Huang C., et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant: 2009; 9 8 1903 1911
129. Palmer S. M., Miralles A. P., Howell D. N., Brazer S. R., Tapson V. F., Davis R. D. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest: 2000; 118 4 1214 1217
130. Cantu E. III, Appel J. Z. III, Hartwig M. G., et al. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg: 2004; 78 4 1142 1151, discussion 11421151
131. Blondeau K., Mertens V., Vanaudenaerde B. A., et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J: 2008; 31 4 707 713
132. Hadjiliadis D., Duane Davis R., Steele M. P., et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant: 2003; 17 4 363 368 (Pubitemid 36958199)
133. Miyagawa-Hayashino A., Wain J. C., Mark E. J. Lung transplantation biopsy specimens with bronchiolitis obliterans or bronchiolitis obliterans organizing pneumonia due to aspiration. Arch Pathol Lab Med: 2005; 129 2 223 226 (Pubitemid 40204803)
134. Palmer S. M., Burch L. H., Davis R. D., et al. The role of innate immunity in acute allograft rejection after lung transplantation. Am J Respir Crit Care Med: 2003; 168 6 628 632 (Pubitemid 37175964)
135. Palmer S. M., Burch L. H., Trindade A. J., et al. Innate immunity influences long-term outcomes after human lung transplant. Am J Respir Crit Care Med: 2005; 171 7 780 785 (Pubitemid 40471150)
136. Palmer S. M., Klimecki W., Yu L., et al. Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. Am J Transplant: 2007; 7 3 693 699 (Pubitemid 46376452)
137. Yoshida S., Haque A., Mizobuchi T., et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant: 2006; 6 4 724 735 (Pubitemid 43345010)
138. Burlingham W. J., Love R. B., Jankowska-Gan E., et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest: 2007; 117 11 3498 3506 (Pubitemid 350097005)
139. Badri L., Murray S., Liu L. X., et al. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med: 2011; 183 8 1062 1070
140. Lama V. N., Smith L., Badri L., et al. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest: 2007; 117 4 989 996 (Pubitemid 46556755)
141. Bröcker V., Länger F., Fellous T. G., et al. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med: 2006; 173 11 1276 1282 (Pubitemid 43848400)
142. Chamberlain D., Maurer J., Chaparro C., Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant: 1994; 13 6 963 971 (Pubitemid 24365575)
143. Hopkins P. M., Aboyoun C. L., Chhajed P. N., et al. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant: 2002; 21 10 1062 1067 (Pubitemid 35190322)
144. Sundaresan S., Trulock E. P., Mohanakumar T., Cooper J. D., Patterson G. A.; Washington University Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg: 1995; 60 5 1341 1346, discussion 13461347
145. Cooper J. D., Billingham M., Egan T., et al. International Society for Heart and Lung Transplantation. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant: 1993; 12 5 713 716 (Pubitemid 23305066)
146. Estenne M., Maurer J. R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant: 2002; 21 3 297 310 (Pubitemid 34224094)
147. Lama V. N., Murray S., Mumford J. A., et al. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med: 2005; 172 3 379 383 (Pubitemid 41026150)
148. Hachem R. R., Chakinala M. M., Yusen R. D., et al. The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med: 2004; 169 4 468 472 (Pubitemid 38187118)
149. Studer S. M., Orens J. B., Rosas I., et al. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant: 2001; 20 11 1158 1166 (Pubitemid 33035077)
150. Van Muylem A., Mélot C., Antoine M., Knoop C., Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart-lung transplantation. Thorax: 1997; 52 7 643 647 (Pubitemid 27342215)
151. Siegel M. J., Bhalla S., Gutierrez F. R., Hildebolt C., Sweet S. Post-lung transplantation bronchiolitis obliterans syndrome: usefulness of expiratory thin-section CT for diagnosis. Radiology: 2001; 220 2 455 462 (Pubitemid 32667184)
152. Bankier A. A., Van Muylem A., Knoop C., Estenne M., Gevenois P. A. Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT. Radiology: 2001; 218 2 533 539 (Pubitemid 32121072)
153. Reynaud-Gaubert M., Thomas P., Badier M., Cau P., Giudicelli R., Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med: 2000; 161 6 1924 1929 (Pubitemid 30418131)
154. Zheng L., Walters E. H., Ward C., et al. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax: 2000; 55 1 53 59 (Pubitemid 30248779)
155. Slebos D. J., Postma D. S., Koëter G. H., Van Der Bij W., Boezen M., Kauffman H. F. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection. J Heart Lung Transplant: 2004; 23 5 532 540 (Pubitemid 38595736)
156. Belperio J. A., Keane M. P., Burdick M. D., et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol: 2002; 169 2 1037 1049 (Pubitemid 34753464)
157. Belperio J. A., Keane M. P., Burdick M. D., et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest: 2001; 108 4 547 556 (Pubitemid 32777734)
158. Belperio J. A., DiGiovine B., Keane M. P., et al. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Transplantation: 2002; 73 4 591 599 (Pubitemid 34193622)
159. Jackson C. H., Sharples L. D., McNeil K., Stewart S., Wallwork J. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant: 2002; 21 6 658 666 (Pubitemid 34626359)
160. Brugière O., Pessione F., Thabut G., et al. Bronchiolitis obliterans syndrome after single-lung transplantation: impact of time to onset on functional pattern and survival. Chest: 2002; 121 6 1883 1889 (Pubitemid 34634410)
161. Tamm M., Sharples L. D., Higenbottam T. W., Stewart S., Wallwork J. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med: 1997; 155 5 1705 1710 (Pubitemid 27216681)
162. Finlen Copeland C. A., Snyder L. D., Zaas D. W., Turbyfill W. J., Davis W. A., Palmer S. M. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med: 2010; 182 6 784 789
163. Lama V. N., Murray S., Lonigro R. J., et al. Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med: 2007; 175 11 1192 1198 (Pubitemid 46855462)
164. Vanaudenaerde B. M., Meyts I., Vos R., et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J: 2008; 32 4 832 843
165. Sato M., Waddell T. K., Wagnetz U., et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant: 2011; 30 7 735 742
166. Verleden G. M., Vos R., Verleden S. E., et al. Survival determinants in lung transplant patients with chronic allograft dysfunction. Transplantation: 2011; 92 6 703 708
167. Kesten S., Maidenberg A., Winton T., Maurer J. Treatment of presumed and proven acute rejection following six months of lung transplant survival. Am J Respir Crit Care Med: 1995; 152 4 Pt 1 1321 1324
168. Dusmet M., Maurer J., Winton T., Kesten S. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant: 1996; 15 9 948 954 (Pubitemid 26320220)
169. Verleden G. M., Buyse B., Delcroix M., et al. Cyclophosphamide rescue therapy for chronic rejection after lung transplantation. J Heart Lung Transplant: 1999; 18 11 1139 1142
170. Cahill B. C., Somerville K. T., Crompton J. A., et al. Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. J Heart Lung Transplant: 2003; 22 2 169 176 (Pubitemid 36173674)
171. Ussetti P., Carreño M. C., de Pablo A., Gamez P., Varela A. Rapamycin and chronic lung rejection. J Heart Lung Transplant: 2004; 23 7 917 918
172. Snell G. I., Esmore D. S., Williams T. J. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest: 1996; 109 4 874 878 (Pubitemid 26113623)
173. Kesten S., Rajagopalan N., Maurer J. Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation: 1996; 61 3 427 430 (Pubitemid 26067919)
174. Brock M. V., Borja M. C., Ferber L., et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant: 2001; 20 12 1282 1290 (Pubitemid 34017313)
175. Garrity E. R. Jr, Villanueva J., Bhorade S. M., Husain A. N., Vigneswaran W. T. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation: 2001; 71 6 773 777 (Pubitemid 32373693)
176. Reams B. D., Musselwhite L. W., Zaas D. W., et al. Alemtuzumab in the treatment of refractory acute rejection and bronchiolitis obliterans syndrome after human lung transplantation. Am J Transplant: 2007; 7 12 2802 2808 (Pubitemid 350045775)
177. Fisher A. J., Rutherford R. M., Bozzino J., Parry G., Dark J. H., Corris P. A. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant: 2005; 5 3 537 543 (Pubitemid 40313345)
178. Salerno C. T., Park S. J., Kreykes N. S., et al. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thorac Cardiovasc Surg: 1999; 117 6 1063 1069 (Pubitemid 29270344)
179. Gottlieb J., Szangolies J., Koehnlein T., Golpon H., Simon A., Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation: 2008; 85 1 36 41
180. Porhownik N. R., Batobara W., Kepron W., Unruh H. W., Bshouty Z. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients. Can Respir J: 2008; 15 4 199 202
181. Dhillon G. S., Valentine V. G., Levitt J., et al. Clarithromycin for prevention of bronchiolitis obliterans syndrome in lung allograft recipients. Clin Transplant: 2012; 26 1 105 110
182. Hartwig M. G., Appel J. Z., Davis R. D. Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin: 2005; 15 3 417 427 (Pubitemid 40848605)
183. Young L. R., Hadjiliadis D., Davis R. D., Palmer S. M. Lung transplantation exacerbates gastroesophageal reflux disease. Chest: 2003; 124 5 1689 1693 (Pubitemid 37433560)
184. Davis R. D. Jr, Lau C. L., Eubanks S., et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg: 2003; 125 3 533 542 (Pubitemid 36373899)
185. Hartwig M. G., Anderson D. J., Onaitis M. W., et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg: 2011; 92 2 462 468; discussion; 468469
186. Brugière O., Thabut G., Castier Y., et al. Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients. Chest: 2003; 123 6 1832 1837 (Pubitemid 36706701)
187. Kawut S. M., Lederer D. J., Keshavjee S., et al. Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med: 2008; 177 1 114 120
188. Aigner C., Jaksch P., Taghavi S., et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases. J Heart Lung Transplant: 2008; 27 1 60 65
189. Krowka M. J., Rosenow E. C. III, Hoagland H. C. Pulmonary complications of bone marrow transplantation. Chest: 1985; 87 2 237 246 (Pubitemid 15174060)
190. Crawford S. W., Hackman R. C. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis: 1993; 147 6 Pt 1 1393 1400 (Pubitemid 23160534)
191. Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant: 1994; 14 04 S19 S28
192. Yen K. T., Lee A. S., Krowka M. J., Burger C. D. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med: 2004; 25 1 189 201 (Pubitemid 38296343)
193. Sirithanakul K., Salloum A., Klein J. L., Soubani A. O. Pulmonary complications following hematopoietic stem cell transplantation: diagnostic approaches. Am J Hematol: 2005; 80 2 137 146 (Pubitemid 41434199)
194. Sharma S., Nadrous H. F., Peters S. G., et al. Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings. Chest: 2005; 128 3 1385 1392 (Pubitemid 41324422)
195. Panoskaltsis-Mortari A., Griese M., Madtes D. K., et al. American Thoracic Society Committee on Idiopathic Pneumonia Syndrome An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med: 2011; 183 9 1262 1279
196. Au B. K., Au M. A., Chien J. W. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant: 2011; 17 7 1072 1078
197. Santo Tomas L. H., Loberiza F. R. Jr, Klein J. P., et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest: 2005; 128 1 153 161 (Pubitemid 40994467)
198. Williams K. M., Chien J. W., Gladwin M. T., Pavletic S. Z. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA: 2009; 302 3 306 314
199. Nakaseko C., Ozawa S., Sakaida E., et al. Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation. Int J Hematol: 2011; 93 3 375 382
200. Beschorner W. E., Saral R., Hutchins G. M., Tutschka P. J., Santos G. W. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med: 1978; 299 19 1030 1036 (Pubitemid 9050580)
201. Roca J., Grañeña A., Rodriguez-Roisin R., Alvarez P., Agusti-Vidal A., Rozman C. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax: 1982; 37 1 77 78 (Pubitemid 12135885)
202. Clark J. G., Schwartz D. A., Flournoy N., Sullivan K. M., Crawford S. W., Thomas E. D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med: 1987; 107 5 648 656 (Pubitemid 18041859)
203. Yokoi T., Hirabayashi N., Ito M., et al. Nagoya BMT Group Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Virchows Arch: 1997; 431 4 275 282 (Pubitemid 27470625)
204. Sánchez J., Torres A., Serrano J., et al. Long-term follow-up of immunosuppressive treatment for obstructive airways disease after allogeneic bone marrow transplantation. Bone Marrow Transplant: 1997; 20 5 403 408 (Pubitemid 27390415)
205. Palmas A., Tefferi A., Myers J. L., et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol: 1998; 100 4 680 687 (Pubitemid 28126099)
206. Dudek A. Z., Mahaseth H., DeFor T. E., Weisdorf D. J. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant: 2003; 9 10 657 666 (Pubitemid 38351785)
207. Ratjen F., Rjabko O., Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant: 2005; 36 2 135 138 (Pubitemid 41030629)
208. Chan C. K., Hyland R. H., Hutcheon M. A., et al. Small-airways disease in recipients of allogeneic bone marrow transplants. An analysis of 11 cases and a review of the literature. Medicine (Baltimore): 1987; 66 5 327 340 (Pubitemid 18020232)
209. Chien J. W., Martin P. J., Flowers M. E., Nichols W. G., Clark J. G. Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant: 2004; 33 7 759 764 (Pubitemid 38499932)
210. Clark J. G., Crawford S. W., Madtes D. K., Sullivan K. M. Obstructive lung disease after allogeneic marrow transplantation: clinical presentation and course. Ann Intern Med: 1989; 111 5 368 376 (Pubitemid 19231290)
211. Curtis D. J., Smale A., Thien F., Schwarer A. P., Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant: 1995; 16 1 169 173
212. Duncan C. N., Buonanno M. R., Barry E. V., Myers K., Peritz D., Lehmann L. Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant: 2008; 41 11 971 975 (Pubitemid 351850502)
213. Holland H. K., Wingard J. R., Beschorner W. E., Saral R., Santos G. W. Bronchiolitis obliterans in bone marrow transplantation and its relationship to chronic graft-v-host disease and low serum IgG. Blood: 1988; 72 2 621 627
214. Marras T. K., Chan C. K. Obliterative bronchiolitis complicating bone marrow transplantation. Semin Respir Crit Care Med: 2003; 24 5 531 542
215. Payne L., Chan C. K., Fyles G., et al. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation. Chest: 1993; 104 1 114 118 (Pubitemid 23204540)
216. Philit F., Wiesendanger T., Archimbaud E., Mornex J. F., Brune J., Cordier J. F. Post-transplant obstructive lung disease ("bronchiolitis obliteranso"): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J: 1995; 8 4 551 558
217. Ringdén O., Remberger M., Ruutu T., et al. Nordic Bone Marrow Transplantation Group Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Blood: 1999; 93 7 2196 2201 (Pubitemid 29153620)
218. Sakaida E., Nakaseko C., Harima A., et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood: 2003; 102 12 4236 4242 (Pubitemid 37487013)
219. Schultz K. R., Green G. J., Wensley D., et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood: 1994; 84 9 3212 3220 (Pubitemid 24328117)
220. Schwarer A. P., Hughes J. M., Trotman-Dickenson B., Krausz T., Goldman J. M. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation. Transplantation: 1992; 54 6 1002 1008 (Pubitemid 23005536)
221. Urbanski S. J., Kossakowska A. E., Curtis J., et al. Idiopathic small airways pathology in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Am J Surg Pathol: 1987; 11 12 965 971 (Pubitemid 18011648)
222. Wyatt S. E., Nunn P., Hows J. M., et al. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax: 1984; 39 12 887 894 (Pubitemid 15211824)
223. Yoshihara S., Tateishi U., Ando T., et al. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant: 2005; 35 12 1195 1200 (Pubitemid 40895176)
224. Forslöw U., Mattsson J., Gustafsson T., Remberger M. Donor lymphocyte infusion may reduce the incidence of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant: 2011; 17 8 1214 1221
225. Endo M., Furukawa H., Aramaki T., et al. Unusual late pulmonary complication in a child after umbilical cord blood transplantation: high-resolution CT-pathologic correlation. J Thorac Imaging: 2005; 20 2 103 106 (Pubitemid 40563433)
226. Ohnuma K., Toyoda Y., Ishida Y., et al. Fatal obstructive lung disease after haploidentical sibling cord blood transplantation. Bone Marrow Transplant: 1998; 21 9 939 941 (Pubitemid 28200862)
227. Frankovich J., Donaldson S. S., Lee Y., Wong R. M., Amylon M., Verneris M. R. High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes. Biol Blood Marrow Transplant: 2001; 7 1 49 57 (Pubitemid 32229503)
228. Paz H. L., Crilley P., Patchefsky A., Schiffman R. L., Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest: 1992; 101 3 775 778
229. Afessa B., Abdulai R. M., Kremers W. K., Hogan W. J., Litzow M. R., Peters S. G. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest: 2012; 141 2 442 450
230. Marras T. K., Chan C. K., Lipton J. H., Messner H. A., Szalai J. P., Laupacis A. Long-term pulmonary function abnormalities and survival after allogeneic marrow transplantation. Bone Marrow Transplant: 2004; 33 5 509 517 (Pubitemid 38425782)
231. Prince D. S., Wingard J. R., Saral R., Santos G. W., Wise R. A. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest: 1989; 96 2 301 306 (Pubitemid 19199540)
232. Chien J. W., Maris M. B., Sandmaier B. M., Maloney D. G., Storb R. F., Clark J. G. Comparison of lung function after myeloablative and 2. Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant: 2005; 11 4 288 296
233. Versluys A. B., Rossen J. W., van Ewijk B., Schuurman R., Bierings M. B., Boelens J. J. Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes. Biol Blood Marrow Transplant: 2010; 16 6 782 791
234. Weigt S. S., Gregson A. L., Deng J. C., Lynch J. P. III, Belperio J. A. Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med: 2011; 32 4 471 493
235. Erard V., Chien J. W., Kim H. W., et al. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis: 2006; 193 12 1619 1625 (Pubitemid 43839464)
236. Hildebrandt G. C., Granell M., Urbano-Ispizua A., et al. Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation. Biol Blood Marrow Transplant: 2008; 14 1 67 74 (Pubitemid 350286740)
237. Nakane T., Nakamae H., Kamoi H., et al. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant: 2008; 42 1 43 49 (Pubitemid 352003423)
238. Epler G. R. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease. Clin Chest Med: 1988; 9 4 551 556
239. Au W. Y., Ho J. C., Lie A. K., et al. Respiratory ciliary function in bone marrow recipients. Bone Marrow Transplant: 2001; 27 11 1147 1151 (Pubitemid 32600287)
240. Hall C. B. Respiratory syncytial virus and parainfluenza virus. N Engl J Med: 2001; 344 25 1917 1928 (Pubitemid 32553362)
241. Belperio J. A. Paying a toll for acute lung allograft rejection. Am J Respir Crit Care Med: 2003; 168 6 623 624 (Pubitemid 37175961)
242. St John R. C., Gadek J. E., Tutschka P. J., Kapoor N., Dorinsky P. M. Analysis of airflow obstruction by bronchoalveolar lavage following bone marrow transplantation. Implications for pathogenesis and treatment. Chest: 1990; 98 3 600 607 (Pubitemid 20352688)
243. Hayes-Jordan A., Benaim E., Richardson S., et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg: 2002; 37 3 446 452 (Pubitemid 34188170)
244. Crawford S. W., Clark J. G. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med: 1993; 14 4 741 749 (Pubitemid 23358013)
245. Patriarca F., Skert C., Sperotto A., et al. Incidence, outcome, and risk factors of late-onset noninfectious pulmonary complications after unrelated donor stem cell transplantation. Bone Marrow Transplant: 2004; 33 7 751 758 (Pubitemid 38499931)
246. Wolff D., Reichenberger F., Steiner B., et al. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplant: 2002; 29 4 357 360 (Pubitemid 34229041)
247. Sullivan K. M., Storek J., Kopecky K. J., et al. A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant: 1996; 2 1 44 53 (Pubitemid 126488195)
248. Lam D. C., Lam B., Wong M. K., et al. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCTa randomized double-blinded placebo-controlled study. Bone Marrow Transplant: 2011; 46 12 1551 1556
249. Or R., Gesundheit B., Resnick I., et al. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation: 2007; 83 5 577 581 (Pubitemid 46440246)
250. Whitford H., Walters E. H., Levvey B., et al. Addition of inhaled corticosteroids to systemic immunosuppression after lung transplantation: a double-blind, placebo-controlled trial. Transplantation: 2002; 73 11 1793 1799 (Pubitemid 34655256)
251. Zheng L., Walters E. H., Wang N., et al. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients. J Heart Lung Transplant: 2004; 23 4 446 455 (Pubitemid 38452696)
252. Bashoura L., Gupta S., Jain A., et al. Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation. Bone Marrow Transplant: 2008; 41 1 63 67
253. Norman B. C., Jacobsohn D. A., Williams K. M., et al. Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patients. Bone Marrow Transplant: 2011; 46 10 1369 1373
254. Foss F. M. Extracorporeal photopheresis in the treatment of graft-vs-host disease. J Cutan Med Surg: 2003; 7 4, Suppl 13 17
255. Foss F. M., DiVenuti G. M., Chin K., et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant: 2005; 35 12 1187 1193 (Pubitemid 40895175)
256. Dall'Amico R., Rossetti F., Zulian F., et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol: 1997; 97 4 848 854 (Pubitemid 27321387)
257. Couriel D. R., Hosing C., Saliba R., et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood: 2006; 107 8 3074 3080
258. Lucid C. E., Savani B. N., Engelhardt B. G., et al. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT. Bone Marrow Transplant: 2011; 46 3 426 429
259. Alcindor T., Gorgun G., Miller K. B., et al. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood: 2001; 98 5 1622 1625
260. Oyan B., Koc Y., Emri S., Kansu E. Improvement of chronic pulmonary graft-vs-host disease manifesting as bronchiolitis obliterans organizing pneumonia following extracorporeal photopheresis. Med Oncol: 2006; 23 1 125 129 (Pubitemid 43787126)
261. Couriel D., Hosing C., Saliba R., et al. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work? Biol Blood Marrow Transplant: 2006; 12 1, Suppl 2 37 40 (Pubitemid 43034110)
262. Frangoul H., Koyama T., Domm J. Etanercept for treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood: 2009; 113 12 2868 2869, author reply 2869
263. Tun H. W., Wallace K. H., Grinton S. F., Khoor A., Burger C. D. Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation. Transplant Proc: 2005; 37 10 4492 4496 (Pubitemid 43016063)
264. Yanik G., Hellerstedt B., Custer J., et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant: 2002; 8 7 395 400
265. Fullmer J. J., Fan L. L., Dishop M. K., Rodgers C., Krance R. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics: 2005; 116 3 767 770 (Pubitemid 44336698)
266. Couriel D. R., Hicks K., Giralt S., Champlin R. E. Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation. Curr Opin Oncol: 2000; 12 6 582 587 (Pubitemid 32039658)
267. Majhail N. S., Schiffer C. A., Weisdorf D. J. Improvement of pulmonary function with imatinib mesylate in bronchiolitis obliterans following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant: 2006; 12 7 789 791 (Pubitemid 43899411)
268. Miano M., Cuzzubbo D., Terranova P., et al. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience. Bone Marrow Transplant: 2009; 43 5 423 427
269. Shapira M. Y., Abdul-Hai A., Resnick I. B., et al. Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant: 2009; 43 4 339 343
270. Kharfan-Dabaja M. A., Mhaskar A. R., Djulbegovic B., Cutler C., Mohty M., Kumar A. Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant: 2009; 15 9 1005 1013
271. Lorillon G., Robin M., Meignin V., et al. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation. Eur Respir J: 2011; 38 2 470 472
272. Mohty M., Marchetti N., El-Cheikh J., Faucher C., Fürst S., Blaise D. Rituximab as salvage therapy for refractory chronic GVHD. Bone Marrow Transplant: 2008; 41 10 909 911 (Pubitemid 351761695)
273. Okamoto M., Akioka K., Ushigome H., et al. Ten-year protocol biopsy findings of renal allografts in the calcineurin inhibitor era. Clin Transplant: 2006; 20 15 16 19 (Pubitemid 44122718)
274. Ratanatharathorn V., Ayash L., Reynolds C., et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant: 2003; 9 8 505 511 (Pubitemid 38351794)
275. Zaja F., Bacigalupo A., Patriarca F., et al. GITMO (Gruppo Italiano Trapianto Midollo Osseo) Treatment of refractory chronic GVHD with rituximab: a GITMO study. Bone Marrow Transplant: 2007; 40 3 273 277 (Pubitemid 47108472)
276. Favaloro R., Bertolotti A., Gomez C., et al. Lung transplant at the Favaloro Foundation: a 13-year experience. Transplant Proc: 2004; 36 6 1689 1691 (Pubitemid 39200404)
277. Rabitsch W., Deviatko E., Keil F., et al. Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation. Transplantation: 2001; 71 9 1341 1343 (Pubitemid 32507159)
278. Gascoigne A., Corris P. Lung transplants in patients with prior bone marrow transplants. Chest: 1994; 105 1 327 (Pubitemid 24029146)
279. Calhoon J. H., Levine S., Anzueto A., Bryan C. L., Trinkle J. K. Lung transplantation in a patient with a prior bone marrow transplant. Chest: 1992; 102 3 948
280. Yam L. Y., Wong R. Bronchiolitis obliterans and rheumatoid arthritis. Report of a case in a Chinese patient on d-penicillamine and review of the literature. Ann Acad Med Singapore: 1993; 22 3 365 368 (Pubitemid 23241985)
281. Wells A. U., du Bois R. M. Bronchiolitis in association with connective tissue disorders. Clin Chest Med: 1993; 14 4 655 666 (Pubitemid 23358006)
282. Scott T. E., Wise R. A., Hochberg M. C., Wigley F. M. HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. Am J Med: 1987; 82 4 765 771
283. Hayakawa H., Sato A., Imokawa S., Toyoshima M., Chida K., Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med: 1996; 154 5 1531 1536 (Pubitemid 26391209)
284. Remy-Jardin M., Remy J., Cortet B., Mauri F., Delcambre B. Lung changes in rheumatoid arthritis: CT findings. Radiology: 1994; 193 2 375 382 (Pubitemid 24338317)
285. Penny W. J., Knight R. K., Rees A. M., Thomas A. L., Smith A. P. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis: 1982; 41 5 469 472 (Pubitemid 12035492)
286. van de Laar M. A., Westermann C. J., Wagenaar S. S., Dinant H. J. Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans. Arthritis Rheum: 1985; 28 1 93 97 (Pubitemid 15193027)
287. Cortot A. B., Cottin V., Miossec P., Fauchon E., Thivolet-Béjui F., Cordier J. F. Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept. Respir Med: 2005; 99 4 511 514 (Pubitemid 40347837)
288. Fathi M., Lundberg I. E., Tornling G. Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med: 2007; 28 4 451 458 (Pubitemid 350194727)
289. Lakhanpal S., Lie J. T., Conn D. L., Martin W. J. II. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis: 1987; 46 1 23 29 (Pubitemid 17225125)
290. Tazelaar H. D., Viggiano R. W., Pickersgill J., Colby T. V. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis: 1990; 141 3 727 733 (Pubitemid 20109165)
291. Ikezoe J., Johkoh T., Kohno N., Takeuchi N., Ichikado K., Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging: 1996; 11 4 250 259 (Pubitemid 26364713)
292. Shinohara T., Hidaka T., Matsuki Y., et al. Rapidly progressive
293. Schwarz M. I., Matthay R. A., Sahn S. A., Stanford R. E., Marmorstein B. L., Scheinhorn D. J. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore): 1976; 55 1 89 104
294. Hsue Y. T., Paulus H. E., Coulson W. F. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival. J Rheumatol: 1993; 20 5 877 879 (Pubitemid 23158487)
295. Imasaki T., Yoshii A., Tanaka S., Ogura T., Ishikawa A., Takahashi T. Polymyositis and Sjögren's syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med: 1996; 35 3 231 235 (Pubitemid 126462533)
296. Highland K. B., Garin M. C., Brown K. K. The spectrum of scleroderma lung disease. Semin Respir Crit Care Med: 2007; 28 4 418 429 (Pubitemid 350194724)
297. Bridges A. J., Hsu K. C., Dias-Arias A. A., Chechani V. Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol: 1992; 19 7 1136 1140
298. Shimizu Y., Tsukagoshi H., Nemoto T., Honma M., Nojima Y., Mori M. Recurrent bronchiolitis obliterans organizing pneumonia in a patient with limited cutaneous systemic sclerosis. Rheumatol Int: 2002; 22 5 216 218 (Pubitemid 35025085)
299. Davison A. G., Heard B. E., McAllister W. A., Turner-Warwick M. E. Cryptogenic organizing pneumonitis. Q J Med: 1983; 52 207 382 394 (Pubitemid 14238631)
300. Boehler A., Vogt P., Speich R., Weder W., Russi E. W. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J: 1996; 9 6 1317 1319 (Pubitemid 26231752)
301. Hakala M., Pääkkö P., Sutinen S., Huhti E., Koivisto O., Tarkka M. Association of bronchiolitis with connective tissue disorders. Ann Rheum Dis: 1986; 45 8 656 662 (Pubitemid 16038567)
302. Yousem S. A. The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol: 1990; 21 5 467 474 (Pubitemid 20165139)
303. Memet B., Ginzler E. M. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med: 2007; 28 4 441 450 (Pubitemid 350194726)
304. Keane M. P., Lynch J. P. III. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax: 2000; 55 2 159 166 (Pubitemid 30245959)
305. Orens J. B., Martinez F. J., Lynch J. P. III. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am: 1994; 20 1 159 193 (Pubitemid 24066016)
306. Kinney W. W., Angelillo V. A. Bronchiolitis in systemic lupus erythematosus. Chest: 1982; 82 5 646 649 (Pubitemid 13234199)
307. Otsuka F., Amano T., Hashimoto N., et al. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med: 1996; 35 4 341 344 (Pubitemid 126484055)
308. Mana F., Mets T., Vincken W., Sennesael J., Vanwaeyenbergh J., Goossens A. The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner's cystitis. Chest: 1993; 104 2 642 644 (Pubitemid 23229560)
309. Matthay R. A., Schwarz M. I., Petty T. L., et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore): 1975; 54 5 397 409
310. Guerry-Force M. L., Müller N. L., Wright J. L., et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am Rev Respir Dis: 1987; 135 3 705 712 (Pubitemid 17041609)
311. Nadorra R. L., Landing B. H. Pulmonary lesions in childhood onset systemic lupus erythematosus: analysis of 26 cases, and summary of literature. Pediatr Pathol: 1987; 7 1 1 18 (Pubitemid 17109054)
312. Gammon R. B., Bridges T. A., al-Nezir H., Alexander C. B., Kennedy J. I. Jr. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest: 1992; 102 4 1171 1174
313. Weber F., Prior C., Kowald E., Schmuth M., Sepp N. Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus. Br J Dermatol: 2000; 143 2 453 455 (Pubitemid 30650428)
314. Sullivan W. D., Hurst D. J., Harmon C. E., et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore): 1984; 63 2 92 107 (Pubitemid 14166821)
315. Lázaro M. A., Maldonado Cocco J. A., Catoggio L. J., Babini S. M., Messina O. D., García Morteo O. Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine (Baltimore): 1989; 68 1 58 65 (Pubitemid 19041253)
316. Prakash U. B. Respiratory complications in mixed connective tissue disease. Clin Chest Med: 1998; 19 4 733 746, ix (Pubitemid 29013315)
317. Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue diseasean apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med: 1972; 52 2 148 159
318. Ito I., Nagai S., Kitaichi M., et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med: 2005; 171 6 632 638 (Pubitemid 40365420)
319. Papiris S. A., Tsonis I. A., Moutsopoulos H. M. Sjögren's Syndrome. Semin Respir Crit Care Med: 2007; 28 4 459 471
320. Lahdensuo A., Korpela M. Pulmonary findings in patients with primary Sjögren's syndrome. Chest: 1995; 108 2 316 319
321. Hatron P. Y., Wallaert B., Gosset D., et al. Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease. Arthritis Rheum: 1987; 30 11 1226 1231 (Pubitemid 18009286)
322. Uffmann M., Kiener H. P., Bankier A. A., Baldt M. M., Zontsich T., Herold C. J. Lung manifestation in asymptomatic patients with primary Sjögren syndrome: assessment with high resolution CT and pulmonary function tests. J Thorac Imaging: 2001; 16 4 282 289 (Pubitemid 33041784)
323. Kelly C., Gardiner P., Pal B., Griffiths I. Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study. Thorax: 1991; 46 3 180 183
324. Deheinzelin D., Capelozzi V. L., Kairalla R. A., Barbas Filho J. V., Saldiva P. H., de Carvalho C. R. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med: 1996; 154 3 Pt 1 794 799 (Pubitemid 26327307)
325. Parambil J. G., Myers J. L., Lindell R. M., Matteson E. L., Ryu J. H. Interstitial lung disease in primary Sjögren syndrome. Chest: 2006; 130 5 1489 1495 (Pubitemid 44786744)
326. Hubscher O., Re R., Iotti R. Cystic lung disease in Sjögren's syndrome. J Rheumatol: 2002; 29 10 2235 2236
327. Kobayashi H., Matsuoka R., Kitamura S., Tsunoda N., Saito K. Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest: 1988; 94 2 438 440
328. Lynch J. P. III, Orens J. B., Kazerooni E. A. Collagen vascular diseases. In: Sperber M., ed. Diffuse Lung Diseases. London Springer-Verlag: 1998; 325 356
329. Martinez F. J., Lynch J. P. III. Collagen vascular disease-associated bronchiolitis obliterans organizing pneumonia. In: Epler G. R., ed. Diseases of the Bronchioles. New York Raven Press: 1994; 347 366
330. Papiris S. A., Maniati M., Constantopoulos S. H., Roussos C., Moutsopoulos H. M., Skopouli F. N. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis: 1999; 58 1 61 64 (Pubitemid 29112952)
331. Cha S. I., Fessler M. B., Cool C. D., Schwarz M. I., Brown K. K. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J: 2006; 28 2 364 369 (Pubitemid 44914237)
332. Papiris S. A., Kalomenidis I., Malagari K., et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med: 2007; 101 1 84 92 (Pubitemid 44835236)
333. Theander E., Henriksson G., Ljungberg O., Mandl T., Manthorpe R., Jacobsson L. T. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis: 2006; 65 6 796 803 (Pubitemid 43799181)
334. Nakamura N., Yamada G., Itoh T., et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren's syndrome. Intern Med: 2002; 41 4 309 311 (Pubitemid 34495548)
335. Hansen L. A., Prakash U. B., Colby T. V. Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc: 1989; 64 8 920 931
336. Usui Y., Kimula Y., Miura H., et al. A case of bronchiolitis obliterans organizing pneumonia associated with primary Sjögren's syndrome who died of superimposed diffuse alveolar damage. Respiration: 1992; 59 2 122 124
337. Hayashi R., Yamashita N., Sugiyama E., et al. A case of primary Sjögren's syndrome with interstitial pneumonia showing bronchiolitis obliterans organizing pneumonia pattern and lymphofollicular formation [in Japanese]. Nihon Kokyuki Gakkai Zasshi: 2000; 38 11 880 884
338. Yoshida K., Mouri T., Kuroda S., et al. A case of Sjögren syndrome associated with bronchiolitis obliterans organizing pneumonia [in Japanese]. Nippon Naika Gakkai Zasshi: 2001; 90 2 329 331
339. Matteson E. L., Ike R. W. Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome. J Rheumatol: 1990; 17 5 676 679 (Pubitemid 20201747)
340. Camus P., Piard F., Ashcroft T., Gal A. A., Colby T. V. The lung in inflammatory bowel disease. Medicine (Baltimore): 1993; 72 3 151 183 (Pubitemid 23157325)
341. Rickli H., Fretz C., Hoffman M., Walser A., Knoblauch A. Severe inflammatory upper airway stenosis in ulcerative colitis. Eur Respir J: 1994; 7 10 1899 1902 (Pubitemid 24337366)
342. Rankin G. B. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am: 1990; 74 1 39 50
343. Tzanakis N., Samiou M., Bouros D., Mouzas J., Kouroumalis E., Siafakas N. M. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med: 1998; 157 2 382 386 (Pubitemid 28090524)
344. Tzanakis N., Bouros D., Samiou M., et al. Lung function in patients with inflammatory bowel disease. Respir Med: 1998; 92 3 516 522 (Pubitemid 28162164)
345. Ben-Noun L. Drug-induced respiratory disorders: incidence, prevention and management. Drug Saf: 2000; 23 2 143 164 (Pubitemid 30601402)
346. Lyle W. H. D-Penicillamine and fatal obliterative bronchiolitis. BMJ: 1977; 1 6053 105
347. Jordan A., Cowan R. E. Reversible pulmonary disease and eosinophilia associated with sulphasalazine. J R Soc Med: 1988; 81 4 233 235 (Pubitemid 18095856)
348. Williams T., Eidus L., Thomas P. Fibrosing alveolitis, bronchiolitis obliterans, and sulfasalazine therapy. Chest: 1982; 81 6 766 768 (Pubitemid 12073347)
349. Patel R. C., Dutta D., Schonfeld S. A. Free-base cocaine use associated with bronchiolitis obliterans organizing pneumonia. Ann Intern Med: 1987; 107 2 186 187 (Pubitemid 17137853)
350. McCarroll K. A., Roszler M. H. Lung disorders due to drug abuse. J Thorac Imaging: 1991; 6 1 30 35
351. Ettinger N. A., Albin R. J. A review of the respiratory effects of smoking cocaine. Am J Med: 1989; 87 6 664 668 (Pubitemid 20006506)
352. Chiu C. Y., Wong K. S., Huang Y. C., Lin T. Y. Bronchiolitis obliterans in children: clinical presentation, therapy and long-term follow-up. J Paediatr Child Health: 2008; 44 3 129 133
353. Colom A. J., Teper A. M. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol: 2009; 44 11 1065 1069
354. Mattiello R., Sarria E. E., Mallol J., et al. Post-infectious bronchiolitis obliterans: can CT scan findings at early age anticipate lung function? Pediatr Pulmonol: 2010; 45 4 315 319
355. Ghanei M., Moqadam F. A., Mohammad M. M., Aslani J. Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med: 2006; 173 3 304 309 (Pubitemid 43209085)
356. Kern D. G., Kuhn C. III, Ely E. W., et al. Flock worker's lung: broadening the spectrum of clinicopathology, narrowing the spectrum of suspected etiologies. Chest: 2000; 117 1 251 259 (Pubitemid 30053647)
357. Kern D. G., Crausman R. S., Durand K. T., Nayer A., Kuhn C. III. Flock worker's lung: chronic interstitial lung disease in the nylon flocking industry. Ann Intern Med: 1998; 129 4 261 272 (Pubitemid 28394570)
358. Eschenbacher W. L., Kreiss K., Lougheed M. D., Pransky G. S., Day B., Castellan R. M. Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med: 1999; 159 6 2003 2008 (Pubitemid 29275076)
359. From the Centers for Disease Control and Prevention From the Centers for Disease Control and Prevention. Fixed obstructive lung disease in workers at a microwave popcorn factoryMissouri, 2000-2002. JAMA: 2002; 287 22 2939 2940
360. Centers for Disease Control and Prevention (CDC) Fixed obstructive lung disease among workers in the flavor-manufacturing industryCalifornia, 2004-2007. MMWR Morb Mortal Wkly Rep: 2007; 56 16 389 393
361. Kanwal R., Kullman G., Piacitelli C., et al. Evaluation of flavorings-related lung disease risk at six microwave popcorn plants. J Occup Environ Med: 2006; 48 2 149 157 (Pubitemid 43237946)
362. Kim T. J., Materna B. L., Prudhomme J. C., et al. Industry-wide medical surveillance of California flavor manufacturing workers: Cross-sectional results. Am J Ind Med: 2010; 53 9 857 865
363. Lockey J. E., Hilbert T. J., Levin L. P., et al. Airway obstruction related to diacetyl exposure at microwave popcorn production facilities. Eur Respir J: 2009; 34 1 63 71
364. Kreiss K., Fedan K. B., Nasrullah M., et al. Longitudinal lung function declines among California flavoring manufacturing workers. Am J Ind Med: 2012; 55 8 657 668
365. Harber P., Saechao K., Boomus C. Diacetyl-induced lung disease. Toxicol Rev: 2006; 25 4 261 272
366. Hubbs A. F., Battelli L. A., Goldsmith W. T., et al. Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring. Toxicol Appl Pharmacol: 2002; 185 2 128 135 (Pubitemid 36062803)
367. Hubbs A. F., Goldsmith W. T., Kashon M. L., et al. Respiratory toxicologic pathology of inhaled diacetyl in Sprague-Dawley rats. Toxicol Pathol: 2008; 36 2 330 344 (Pubitemid 351534484)
368. Larsen S. T., Alarie Y., Hammer M., Nielsen G. D. Acute airway effects of diacetyl in mice. Inhal Toxicol: 2009; 21 13 1123 1128
369. Morgan D. L., Flake G. P., Kirby P. J., Palmer S. M. Respiratory toxicity of diacetyl in C57BL/6 mice. Toxicol Sci: 2008; 103 1 169 180 (Pubitemid 351524488)
370. Palmer S. M., Flake G. P., Kelly F. L., et al. Severe airway epithelial injury, aberrant repair and bronchiolitis obliterans develops after diacetyl instillation in rats. PLoS ONE: 2011; 6 3 e17644
371. Akpinar-Elci M., Stemple K. J., Elci O. C., Dweik R. A., Kreiss K., Enright P. L. Exhaled nitric oxide measurement in workers in a microwave popcorn production plant. Int J Occup Environ Health: 2006; 12 2 106 110 (Pubitemid 44474275)
372. Akpinar-Elci M., Stemple K. J., Enright P. L., et al. Induced sputum evaluation in microwave popcorn production workers. Chest: 2005; 128 2 991 997 (Pubitemid 41140537)
373. Mathews J. M., Watson S. L., Snyder R. W., Burgess J. P., Morgan D. L. Reaction of the butter flavorant diacetyl (2,3-butanedione) with N-α-acetylarginine: a model for epitope formation with pulmonary proteins in the etiology of obliterative bronchiolitis. J Agric Food Chem: 2010; 58 24 12761 12768
374. Kovacic P., Cooksy A. L. Electron transfer as a potential cause of diacetyl toxicity in popcorn lung disease. Rev Environ Contam Toxicol: 2010; 204 133 148
375. Boag A. H., Colby T. V., Fraire A. E., et al. The pathology of interstitial lung disease in nylon flock workers. Am J Surg Pathol: 1999; 23 12 1539 1545
376. Weiland D. A., Lynch D. A., Jensen S. P., et al. Thin-section CT findings in flock worker's lung, a work-related interstitial lung disease. Radiology: 2003; 227 1 222 231 (Pubitemid 36384203)
377. Prezant D. S L, TK A. Pulmonary and airway complications related to September 11th. In: Lynch J. P. III., ed. Interstitial Pulmonary and Bronchiolar Disorders. New York, NY Informa Healthcare USA: 2008; 227 573 590
378. Banauch G. I., Dhala A., Prezant D. J. Pulmonary disease in rescue workers at the World Trade Center site. Curr Opin Pulm Med: 2005; 11 2 160 168 (Pubitemid 40279925)
379. Banauch G. I., Alleyne D., Sanchez R., et al. Persistent hyperreactivity and reactive airway dysfunction in firefighters at the World Trade Center. Am J Respir Crit Care Med: 2003; 168 1 54 62 (Pubitemid 37046633)
380. Brackbill R. M., Thorpe L. E., DiGrande L., et al. Surveillance for World Trade Center disaster health effects among survivors of collapsed and damaged buildings. MMWR Surveill Summ: 2006; 55 2 1 18
381. Prezant D. J., Weiden M., Banauch G. I., et al. Cough and bronchial responsiveness in firefighters at the World Trade Center site. N Engl J Med: 2002; 347 11 806 815 (Pubitemid 34988339)
382. Wagner V. L., Radigan M. S., Roohan P. J., Anarella J. P., Gesten F. C. Asthma in Medicaid managed care enrollees residing in New York City: results from a post-World Trade Center disaster survey. J Urban Health: 2005; 82 1 76 89 (Pubitemid 41214131)
383. Wheeler K., McKelvey W., Thorpe L., et al. Asthma diagnosed after 11 September 2001 among rescue and recovery workers: findings from the World Trade Center Health Registry. Environ Health Perspect: 2007; 115 11 1584 1590
384. Centers for Disease Control and Prevention (CDC) Self-reported increase in asthma severity after the September 11 attacks on the World Trade CenterManhattan, New York, 2001. MMWR Morb Mortal Wkly Rep: 2002; 51 35 781 784
385. Herbert R., Moline J., Skloot G., et al. The World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening program. Environ Health Perspect: 2006; 114 12 1853 1858 (Pubitemid 44873685)
386. Skloot G., Goldman M., Fischler D., et al. Respiratory symptoms and physiologic assessment of ironworkers at the World Trade Center disaster site. Chest: 2004; 125 4 1248 1255 (Pubitemid 38501335)
387. Izbicki G., Chavko R., Banauch G. I., et al. World Trade Center "sarcoid-likeo" granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest: 2007; 131 5 1414 1423 (Pubitemid 46762347)
388. Safirstein B. H., Klukowicz A., Miller R., Teirstein A. Granulomatous pneumonitis following exposure to the World Trade Center collapse. Chest: 2003; 123 1 301 304 (Pubitemid 36126748)
389. Rom W. N., Weiden M., Garcia R., et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am J Respir Crit Care Med: 2002; 166 6 797 800
390. Lai R. S., Chiang A. A., Wu M. T., et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet: 1996; 348 9020 83 85 (Pubitemid 26234354)
391. Lin T. J., Lu C. C., Chen K. W., Deng J. F. Outbreak of obstructive ventilatory impairment associated with consumption of Sauropus androgynus vegetable. J Toxicol Clin Toxicol: 1996; 34 1 1 8
392. Chen C. W., Hsiue T. R., Chen K. W., Chang H. Y., Chen C. R., Yang B. C. Increased IL-5 and IL-10 transcription in bronchial cells after Sauropus androgynus ingestion. J Formos Med Assoc: 1996; 95 9 699 702
393. Yang C. F., Wu M. T., Chiang A. A., et al. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus. AJR Am J Roentgenol: 1997; 168 4 1045 1050 (Pubitemid 27146943)
394. Soubani A. O., Pandya C. M. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther: 2010; 3 3 143 157
395. Wang J. S., Tseng H. H., Lai R. S., Hsu H. K., Ger L. P. Sauropus androgynus-constrictive obliterative bronchitis/bronchiolitishistopathological study of pneumonectomy and biopsy specimens with emphasis on the inflammatory process and disease progression. Histopathology: 2000; 37 5 402 410
396. Hsiue T. R., Guo Y. L., Chen K. W., Chen C. W., Lee C. H., Chang H. Y. Dose-response relationship and irreversible obstructive ventilatory defect in patients with consumption of Sauropus androgynus. Chest: 1998; 113 1 71 76 (Pubitemid 28044927)
397. Liote H., Porte J. M., Postal M. J., Martin de Lassalle E., Derenne J. P. [Bronchiolitis obliterans, pneumocystosis and HIV infection]. Rev Mal Respir: 1990; 7 6 603 607
398. Khater F. J., Moorman J. P., Myers J. W., Youngberg G., Sarubbi F. A. Bronchiolitis obliterans organizing pneumonia as a manifestation of AIDS: case report and literature review. J Infect: 2004; 49 2 159 164 (Pubitemid 38967351)
399. Mauskar A., Shanbag P., Dadge D. Bronchiolitis obliterans in a child with HIV infection. Indian J Pediatr: 2011; 78 1 112 114
400. Díaz F., Collazos J., Martinez E., Mayo J. Bronchiolitis obliterans in a patient with HIV infection. Respir Med: 1997; 91 3 171 173 (Pubitemid 27122668)
401. Laguna del Estal P., Martín T., Martín F., López E. [Obliterating bronchiolitis in a patient with human immunodeficiency virus infection]. Med Clin (Barc): 1991; 97 16 638
402. Nousari H. C., Deterding R., Wojtczack H., et al. The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med: 1999; 340 18 1406 1410 (Pubitemid 29205404)
403. Nguyen V. T., Ndoye A., Bassler K. D., et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol: 2001; 137 2 193 206 (Pubitemid 32163671)
404. Hasegawa Y., Shimokata K., Ichiyama S., Saito H. Constrictive bronchiolitis obliterans and paraneoplastic pemphigus. Eur Respir J: 1999; 13 4 934 937 (Pubitemid 29234803)
405. Gamm D. M., Harris A., Mehran R. J., Wood M., Foster C. S., Mootha V. V. Mucous membrane pemphigoid with fatal bronchial involvement in a seventeen-year-old girl. Cornea: 2006; 25 4 474 478 (Pubitemid 44620137)
406. Davies S. J., Gosney J. R., Hansell D. M., et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax: 2007; 62 3 248 252 (Pubitemid 46579807)
407. Miller R. R., Müller N. L. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumors. Am J Surg Pathol: 1995; 19 6 653 658
408. Cohen A. J., King T. E. Jr, Gilman L. B., Magill-Solc C., Miller Y. E. High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med: 1998; 158 5 Pt 1 1593 1599
409. Poletti V., Casoni G., Chilosi M., Zompatori M. Diffuse panbronchiolitis. Eur Respir J: 2006; 28 4 862 871 (Pubitemid 46332008)
410. Keicho N., Tokunaga K., Nakata K., et al. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med: 1998; 158 3 846 850 (Pubitemid 28450801)
411. Kudoh S., Keicho N. Diffuse panbronchiolitis. Semin Respir Crit Care Med: 2003; 24 5 607 618
412. Sugiyama Y., Kudoh S., Maeda H., Suzaki H., Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis: 1990; 141 6 1459 1462 (Pubitemid 20201342)
413. Sugiyama Y., Ohno S., Kano S., Maeda H., Kitamura S. Diffuse panbronchiolitis and rheumatoid arthritis: a possible correlation with HLA-B54. Intern Med: 1994; 33 10 612 614
414. Park M. H., Kim Y. W., Yoon H. I., et al. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am J Respir Crit Care Med: 1999; 159 2 526 529 (Pubitemid 29084876)
415. Keicho N., Ohashi J., Tamiya G., et al. Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis. Am J Hum Genet: 2000; 66 2 501 507 (Pubitemid 30468828)
416. Fitzgerald J. E., King T. E. Jr, Lynch D. A., Tuder R. M., Schwarz M. I. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med: 1996; 154 2 Pt 1 497 503 (Pubitemid 26269125)
417. Martinez J. A., Guimarães S. M., Ferreira R. G., Pereira C. A. Diffuse panbronchiolitis in Latin America. Am J Med Sci: 2000; 319 3 183 185 (Pubitemid 30395203)
418. Kudoh S., Azuma A., Yamamoto M., Izumi T., Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med: 1998; 157 6 Pt 1 1829 1832
419. Homma S., Sakamoto S., Kawabata M., et al. Comparative clinicopathology of obliterative bronchiolitis and diffuse panbronchiolitis. Respiration: 2006; 73 4 481 487
420. Mukae H., Hirota M., Kohno S., et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis: 1993; 148 3 744 751 (Pubitemid 23263789)
421. Kadota J., Mukae H., Tomono K., Kohno S., Nasu M. Efficacy of long-term macrolide antibiotic therapy in patients with diffuse panbronchiolitis: comparison between HLA-B54-positive and -negative cases. Int J Antimicrob Agents: 2004; 24 6 550 554 (Pubitemid 39536108)
422. Tanimoto H. A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. Antibiot Chemother: 1991; 44 94 98
423. Jaffé A., Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol: 2001; 31 6 464 473 (Pubitemid 32523640)
424. King M. S., Eisenberg R., Newman J. H., et al. Constrictive bronchiolitis in soldiers returning from Iraq and Afghanistan. N Engl J Med: 2011; 365 3 222 230